Human Health Holdings Limited Issues Supplemental Announcement on Profit Guarantee Non-Fulfilment Relating to Acquisition of Monarch Dental Clinic Limited

Key Points

• Profit Guarantee Non-Fulfilment: Human Health Holdings Limited (“the Company”) announces the non-fulfilment of the profit guarantee related to its acquisition of a 75% stake in Monarch Dental Clinic Limited.
• Extension of Guarantee Period: The guarantee period has been formally extended by two months to adjust for the actual completion date of the acquisition, covering the period from 1 March 2025 to 28 February 2030.
• Pro-Rated Guarantee Calculation: The profit guarantee for the ten months ended 31 December 2025 is now subject to a pro-rated adjustment.
• Shortfall and Compensation: The profit for the ten months ended 31 December 2025 was HK\$4,146,000, against a pro-rated guarantee amount of HK\$6,167,000. A shortfall of HK\$2,021,000 was identified, of which 75% (HK\$1,516,000) was paid by the Vendor and Dr. Cheung to the Purchaser.
• Director’s Opinion: The Board, including independent non-executive Directors, believes the extension is fair, reasonable, and in the best interest of shareholders. They also confirm that the payment of the shortfall fulfills the Vendor’s obligations under the profit guarantee and that the shortfall will not have a material adverse impact on the Group’s financial position or operations.

Details and Potential Share Price Impact

Human Health Holdings Limited has provided a supplemental update regarding the previously announced non-fulfilment of the profit guarantee associated with its acquisition of a controlling 75% interest in Monarch Dental Clinic Limited. The acquisition was completed on 28 February 2025, which meant that the Company and its shareholders were only entitled to the profits generated from 1 March 2025 to 31 December 2025 (ten months) rather than the full financial year.

To address the timing mismatch, the parties—the Vendor, Purchaser, Company, and Dr. Cheung—agreed in writing on 20 April 2026 to extend the profit guarantee period by two months, ensuring it accurately reflects the period in which the new owners were entitled to profits. The guarantee period now runs from 1 March 2025 to 28 February 2030. Importantly, a pro-rated calculation will apply for the periods from 1 March 2025 to 31 December 2025 and from 1 January 2030 to 28 February 2030.

According to the audited financial statements for the year ended 31 December 2025, Monarch Dental Clinic Limited posted a profit of approximately HK\$4,146,000 for the ten months post-acquisition. The adjusted guarantee amount for that period was HK\$6,167,000, resulting in a shortfall of HK\$2,021,000. In accordance with the guarantee terms, the Vendor and Dr. Cheung paid the Purchaser 75% of this shortfall, equating to approximately HK\$1,516,000, on 20 April 2026.

The Board, including the independent non-executive Directors, reviewed and approved the extension and the pro-rated calculation method, concluding that it is both fair and reasonable. They emphasize that the actual length of the guarantee period remains unchanged, and that the extension simply ensures that the guarantee aligns with the period in which the Purchaser is entitled to the profits.

Implications for Shareholders

• Adjusted Guarantee Period: The profit guarantee period now matches the actual time frame of the Company’s entitlement, minimizing ambiguity and potential disputes over entitlement to profits.
• Vendor Fulfillment: Shareholders should note that the Vendor and Dr. Cheung have met their obligations by paying the agreed portion of the shortfall, indicating that the risk of further claims or disputes relating to this aspect of the acquisition is low.
• Impact on Financials: The Directors believe that the shortfall and its settlement will not have a material adverse impact on the Group’s overall financial position or business operations.
• Price Sensitivity: The settlement of the profit guarantee shortfall and the formal extension of the guarantee period provide greater clarity and certainty to shareholders. While the shortfall payment is modest relative to the Company’s size, the transparent handling of the matter could be seen as positive for corporate governance, and the absence of material financial impact may reassure investors.

Board Composition

As of the announcement date, the Board consists of Mr. Chan Kin Ping, BBS, JP (also Chief Executive Officer), Dr. Pang Lai Sheung, and Mr. Poon Chun Pong as executive Directors, and Dr. Lui Sun Wing, Mr. Chan Yue Kwong Michael, and Mr. Chan Hey Man as independent non-executive Directors.

Disclaimer: This article is prepared for informational purposes only and does not constitute investment advice. Readers should consult professional advisors before making any investment decisions. The information is based on the official announcement of Human Health Holdings Limited dated 20 April 2026 and other public disclosures as of that date. Actual outcomes and impacts may differ from those anticipated in this article.

View HUMAN HEALTH Historical chart here